Skip to content past banner and navigation links

COVID-19 is an emerging, rapidly evolving situation


Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Get the latest COVID-19 GWAS Results from GRASP: https://grasp.nhlbi.nh.gov/COVID19GWASResults.aspx

 

COVID-19 GWAS Results -- for public download/use

This site compiles COVID-19 genetic scan results for immediate public download and use from any source permitting such use. Right click links provided here and select “open link in a new tab” to stay on this webpage.

Prior to 07/14/2020: The use of the term “positive” below denotes a positive or assumed positive COVID-19 case based on study definitions. “Negative” indicates someone who has tested negative or presumed negative based on study definitions for COVID-19. “Unknown” indicates population control samples who may not have been tested or may not yet have results.

Between 07/14/2020 and 09/08/2020: COVID-19 deaths (ICD 10 U071) or inpatient diagnosis of COVID-19 (ICD 10 U071) were also added to “positive”. When new death data are released by UK BioBank, six COVID-19 death GWAS will be conducted in addition to COVID-19 GWAS.

From 10/16/2020 and on: COVID-19 deaths (ICD 10 U071), inpatient diagnosis of COVID-19 (ICD 10 U071), primary care clinical data indicating COVID-19 (both TPP/CTV3 and EMIS/SNOMED CT coding systems – see below) were also added to “positive”.

COVID-19 in TPP/CTV3 coding system (01/31/2020 or later)
Y228d: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation)
Y20d1: Severe acute respiratory syndrome coronavirus 2 detected (finding)
Y20fa: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210a: Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210b: Infection of upper respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210e: Detection of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction technique (procedure)
Y23f7: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) detection result positive

COVID-19 in EMIS/SNOMED CT coding system (01/31/2020 or later)
EMISNQCO303: 2019-nCoV (Wuhan) infection
186747009: Coronavirus infection (disorder)
12802201000006101: Confirmed 2019-nCoV (novel coronavirus) infection
1240581000000104: 2019-nCoV (novel coronavirus) detected
1300721000000109: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation)
1240751000000100: Disease caused by 2019-nCoV (novel coronavirus)
1240561000000108: Encephalopathy caused by 2019-nCoV (novel coronavirus)
1240571000000101: Gastroenteritis caused by 2019-nCoV (novel coronavirus)
1240531000000103: Myocarditis caused by 2019-nCoV (novel coronavirus)
1240521000000100: Otitis media caused by 2019-nCoV (novel coronavirus)
1240551000000105: Pneumonia caused by 2019-nCoV (novel coronavirus)
1240541000000107: Upper respiratory tract infection caused by 2019-nCoV (novel coronavirus)
1240511000000106: Detection of 2019-nCoV (novel coronavirus) using polymerase chain reaction technique
1240381000000105: Severe acute respiratory syndrome coronavirus 2 (organism)

From 11/03/2020 and on: We added hospitalized COVID-19 GWAS and severe COVID-19 GWAS with primary care data (both TPP/CTV3 and EMIS/SNOMED CT) being released by UKBB. A hospitalized COVID-19 case is defined by a sample with inpatient diagnosis of COVID-19 (ICD 10 U071). A severe COVID-19 case is defined by a sample with COVID-19 death (ICD 10 U071) or with inpatient diagnosis of both COVID-19 and dependence on respirator (ICD 10 Z991 and Z9911) in the same instance index, or a COVID-10 case with advanced respiratory support (from inpatient critical care data). Due to limited case samples, currently we only conducted both hospitalized and sever COVID-19 GWAS for European and overall samples in UKBB – with 3 additional non-European GWAS for hospitalized COVID-19.

After each COVID-19 release of UK Biobank data (https://www.ukbiobank.ac.uk/2020/04/covid/) we are calculating GWAS summary statistics and releasing them to this site.

  • GWAS were conducted with SAIGE (https://github.com/weizhouUMICH/SAIGE) adjusted for baseline age, sex and 10 principal components
  • European ancestry (EA) only case/controls (as sample N increases for other groups additional analyses will be considered)
  • Two analyses (06/05/2020 or earlier):
    • Positive COVID-19 tests vs. Negative only COVID-19 tests (files with name whites)
    • Positive COVID-19 tests vs. All UKBioBank EA with either negative tests or no known tests (files with name “ALLwhites”)
  • Eighteen analyses (06/18/2020):
    • COVID-19 positive vs. COVID-19 negative in ALL UKBB tested samples (files with name UKBB_covid19_ALLtested)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_covid19_ALL)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) UKBB tested samples (files with name UKBB_covid19_EURtested)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) UKBB samples (files with name UKBB_covid19_EUR)
    • COVID-19 positive vs. COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_covid19_ALLtested_F)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_covid19_ALL_F)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) Female UKBB tested samples (files with name UKBB_covid19_EURtested_F)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) Female UKBB samples (files with name UKBB_covid19_EUR_F)
    • COVID-19 positive vs. COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_covid19_ALLtested_M)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_covid19_ALL_M)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) Male UKBB tested samples (files with name UKBB_covid19_EURtested_M)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) Male UKBB samples (files with name UKBB_covid19_EUR_M)
    • COVID-19 positive vs. COVID-19 negative in African (AFR) UKBB tested samples (files with name UKBB_covid19_AFRtested)
    • COVID-19 positive vs. COVID-19 negative or untested in African (AFR) UKBB samples (files with name UKBB_covid19_AFR)
    • COVID-19 positive vs. COVID-19 negative in South Asian (SAS) UKBB tested samples (files with name UKBB_covid19_SAStested)
    • COVID-19 positive vs. COVID-19 negative or untested in South Asian (SAS) UKBB samples (files with name UKBB_covid19_SAS)
    • COVID-19 positive vs. COVID-19 negative in OTHER ancestry UKBB tested samples (files with name UKBB_covid19_OTHERtested)
    • COVID-19 positive vs. COVID-19 negative or untested in OTHER ancestry UKBB samples (files with name UKBB_covid19_OTHER)
  • Six COVID-19 death analyses in addition to above 18 analyses (07/14/2020):
    • COVID-19 death vs. COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_death_ALL)
    • COVID-19 death vs. COVID-19 negative or untested in European (EUR) UKBB samples (files with name UKBB_death_EUR)
    • COVID-19 death vs. COVID-19 positive survivors in ALL UKBB tested positive samples (files with name UKBB_death_ALLpstv)
    • COVID-19 death vs. COVID-19 positive survivors in European (EUR) UKBB tested positive samples (files with name UKBB_death_EURpstv)
    • COVID-19 death vs. COVID-19 positive survivors and negative in ALL UKBB tested samples (files with name UKBB_death_ALLtested)
    • COVID-19 death vs. COVID-19 positive survivors and negative in European (EUR) UKBB tested samples (files with name UKBB_death_EURtested)
  • Two analyses in addition to the above 24 analyses (08/04/2020):
    • COVID-19 positive vs. COVID-19 negative in non-European (nEUR) UKBB tested samples (files with name UKBB_covid19_nEURtested)
    • COVID-19 positive vs. COVID-19 negative or untested in non-European (nEUR) UKBB samples (files with name UKBB_covid19_nEUR)
  • Twenty-one hospitalized COVID-19 analyses (11/03/2020):
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in ALL UKBB tested samples (files with name UKBB_hsptl_ALLtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_hsptl_ALL)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in European (EUR) UKBB tested positive samples (files with name UKBB_hsptl_EURpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in EUR UKBB tested samples (files with name UKBB_hsptl_EURtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR UKBB samples (files with name UKBB_hsptl_EUR)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in non-European (nEUR) UKBB tested positive samples (files with name UKBB_hsptl_nEURpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in nEUR UKBB tested samples (files with name UKBB_hsptl_nEURtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in nEUR UKBB samples (files with name UKBB_hsptl_nEUR)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL Female UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_hsptl_ALLtested_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_hsptl_ALL_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in EUR Female UKBB tested positive samples (files with name UKBB_hsptl_EURpstv_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in EUR Female UKBB tested samples (files with name UKBB_hsptl_EURtested_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR Female UKBB samples (files with name UKBB_hsptl_EUR_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL Male UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_hsptl_ALLtested_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_hsptl_ALL_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in EUR Male UKBB tested positive samples (files with name UKBB_hsptl_EURpstv_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive or COVID-19 negative in EUR Male UKBB tested samples (files with name UKBB_hsptl_EURtested_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR Male UKBB samples (files with name UKBB_hsptl_EUR_M)
  • Eighteen severe COVID-19 analyses (11/03/2020):
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL UKBB tested positive samples (files with name UKBB_severe_ALLpstv)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in ALL UKBB tested samples (files with name UKBB_severe_ALLtested)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_severe_ALL)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in European (EUR) UKBB tested positive samples (files with name UKBB_severe_EURpstv)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in EUR UKBB tested samples (files with name UKBB_severe_EURtested)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR UKBB samples (files with name UKBB_severe_EUR)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL Female UKBB tested positive samples (files with name UKBB_severe_ALLpstv_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_severe_ALLtested_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_severe_ALL_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in EUR Female UKBB tested positive samples (files with name UKBB_severe_EURpstv_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in EUR Female UKBB tested samples (files with name UKBB_severe_EURtested_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR Female UKBB samples (files with name UKBB_severe_EUR_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL Male UKBB tested positive samples (files with name UKBB_severe_ALLpstv_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_severe_ALLtested_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_severe_ALL_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in EUR Male UKBB tested positive samples (files with name UKBB_severe_EURpstv_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive or COVID-19 negative in EUR Male UKBB tested samples (files with name UKBB_severe_EURtested_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR Male UKBB samples (files with name UKBB_severe_EUR_M)

Summary statistics are for UK Biobank (v.3) imputed genome-wide association (GWAS) studies of COVID-19 test positives with variant filters of imputation quality INFO score >0.3, minor allele count (MAC) > 2, minor allele frequency > 0.0001. Note allele2 is coded allele. See SAIGE output description here: https://github.com/weizhouUMICH/SAIGE/wiki/Genetic-association-tests-using-SAIGE.

Ellinghaus, Degenhardt et al.
Meta-analysis of Spanish and Italian COVID19 cases with respiratory failure
NOTE: full GWAS files are GRCh38 build position whereas top results and annotated files have been Lifted Over to GRCh37.

COVID-19 Host Genetics initiative results provided under Creative Commons License. This includes meta-analyses of international case/control samples with a larger sample size than UKBB alone. These analyses may also have greater test/population ascertainment and genetic heterogeneity effects. If you have samples to contribute we urge you to consider joining. See also https://www.covid19hg.org/blog/ and https://www.nature.com/articles/s41431-020-0636-6

Annotation of all top results P<1E-5 was done from several sources:

All files are in compressed Gzip format.
Send questions, comments or requests to add data or analysis to: ming-huei.chen@nih.gov, florian.thibord@nih.gov, and johnsonad2@nih.gov


Data Source Release Date Description # Cases / Controls Ancestry    Sex    # variants (Million) # Top (P<1E-5) Summary Stats(full) Top Annotated Top in Grasp Top in EBI Top in GTeX Top in eQTLdb     Comments    
UKBB 12.04.20 Positive vs. Negative (tested) 6,803 / 32,205 European M and F 38.07M 460 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 6,803 / 452,447 European M and F 38.06M 593 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 7,435 / 34,362 Mixed M and F 48.51M 584 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 7,435 / 479,885 Mixed M and F 47.70M 688 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 174 / 610 African M and F 26.07M 190 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 174 / 7,470 African M and F 43.68M 520 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 282 / 773 South Asian M and F 18.50M 245 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 282 / 9,135 South Asian M and F 41.98M 366 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 176 / 774 Other M and F 25.23M 368 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 176 / 10,833 Other M and F 61.41M 500 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 632 / 2,157 Non European M and F 38.96M 413 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 632 / 27,438 Non European M and F 66.62M 635 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,438 / 17,065 European F 37.99M 381 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,438 / 245,861 European F 38.11M 393 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,752 / 18,252 Mixed F 48.95M 616 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,752 / 260,477 Mixed F 47.88M 552 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,365 / 15,140 European M 37.92M 876 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,365 / 206,586 European M 37.98M 449 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Negative (tested) 3,683 / 16,110 Mixed M 47.72M 476 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 12.04.20 Positive vs. Population 3,683 / 219,408 Mixed M 47.45M 458 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 5,356 / 28,118 European M and F 38.05M 472 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 5,356 / 453,894 European M and F 38.06M 557 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 5,868 / 30,028 Mixed M and F 48.59M 604 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 5,868 / 481,452 Mixed M and F 47.70M 644 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 147 / 542 African M and F 25.24M 169 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 147 / 7,497 African M and F 43.68M 351 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 232 / 685 South Asian M and F 17.60M 266 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 232 / 9,185 South Asian M and F 41.98M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 133 / 683 Other M and F 23.97M 328 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 133 / 10,876 Other M and F 61.41M 364 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 512 / 1,910 Non European M and F 37.06M 387 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 512 / 27,558 Non European M and F 66.62M 688 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,656 / 14,838 European F 37.95M 455 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,656 / 246,643 European F 38.11M 470 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,906 / 15,886 Mixed F 49.09M 589 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,906 / 261,323 Mixed F 47.88M 508 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,700 / 13,280 European M 37.85M 571 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,700 / 207,251 European M 37.98M 440 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Negative (tested) 2,962 / 14,142 Mixed M 47.67M 452 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.25.20 Positive vs. Population 2,962 / 220,129 Mixed M 47.45M 428 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 3,962 / 25,845 European M and F 38.06M 427 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 3,962 / 455,288 European M and F 38.06M 500 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 4,372 / 27,629 Mixed M and F 48.73M 511 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 4,372 / 482,948 Mixed M and F 47.70M 648 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 130 / 508 African M and F 24.76M 154 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 130 / 7,514 African M and F 43.68M 352 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 180 / 645 South Asian M and F 16.96M 181 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 180 / 9,237 South Asian M and F 41.98M 290 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 100 / 631 Other M and F 23.15M 276 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 100 / 10,909 Other M and F 61.41M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 410 / 1,784 Non European M and F 35.82M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 410 / 27,660 Non European M and F 66.62M 477 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 1,953 / 13,591 European F 37.95M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 1,953 / 247,346 European F 38.11M 363 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,159 / 14,564 Mixed F 42.21M 504 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,159 / 262,070 Mixed F 47.88M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,009 / 12,254 European M 37.43M 397 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,009 / 207,942 European M 37.98M 491 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,213 / 13,065 Mixed M 47.81M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,213 / 220,878 Mixed M 47.45M 521 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Population 418 / 486,902 Mixed M and F 47.70M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Population 377 / 458,873 European M and F 38.06M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Positive Survivor 418 / 3,954 Mixed M and F 33.64M 298 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Positive Survivor 377 / 3,585 European M and F 24.36M 202 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Tested Survivor 418 / 31,583 Mixed M and F 48.73M 573 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Tested Survivor 377 / 29,430 European M and F 38.07M 363 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 678 / 458,572 European M and F 38.06M 575 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 678 / 3,284 European M and F 24.36M 271 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 678 / 29,129 European M and F 38.07M 524 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 794 / 486,526 Mixed M and F 47.70M 522 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 794 / 3,578 Mixed M and F 33.64M 376 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 794 / 31,207 Mixed M and F 48.73MM 573 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 116 / 27,954 Non European M and F 66.62M 434 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 116 / 294 Non European M and F 20.80M 140 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 116 / 2,078 Non European M and F 35.82M 227 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 246 / 249,053 European F 38.11M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 246 / 1,707 European F 19.11M 145 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 246 / 15,298 European F 37.95M 281 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 297 / 263,932 Mixed F 47.88M 378 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 297 / 1,862 Mixed F 26.19M 151 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 297 / 16,426 Mixed F 49.21M 454 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 432 / 209,519 European M 37.98M 372 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 432 / 1,577 European M 19.24M 187 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 432 / 13,831 European M 37.43M 424 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 497 / 222,594 Mixed M 47.45M 484 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 497 / 1,716 Mixed M 25.51M 215 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 497 / 14,781 Mixed M 47.81M 532 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 421 / 458,829 European M and F 38.06M 384 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 421 / 3,541 European M and F 24.36M 200 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 421 / 29,386 European M and F 38.07M 273 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 474 / 486,846 Mixed M and F 47.70M 378 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 474 / 3,898 Mixed M and F 33.64M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 474 / 31,527 Mixed M and F 48.73M 436 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 146 / 249,153 European F 38.11M 276 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 146 / 1,807 European F 19.11M 233 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 146 / 15,398 European F 37.95M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 171 / 264,058 Mixed F 47.88M 441 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 171 / 1,988 Mixed F 26.19M 235 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 171 / 16,552 Mixed F 49.21M 488 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 275 / 209,676 European M 37.98M 329 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 275 / 1,734 European M 19.24M 168 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 275 / 13,988 European M 37.43M 284 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 303 / 222,788 Mixed M 47.45M 296 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 303 / 1,910 Mixed M 25.51M 177 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 303 / 14,975 Mixed M 47.81M 325 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 2,727 / 23,249 European M and F 38.03M 323 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 2,727 / 456,523 European M and F 38.06M 389 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 3,050 / 24,853 Mixed M and F 48.79M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 3,050 / 484,270 Mixed M and F 47.70M 451 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 114 / 452 African M and F 24.05M 171 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 114 / 7,530 African M and F 43.68M 272 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 133 / 587 South Asian M and F 16.21M 173 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 133 / 9,284 South Asian M and F 41.98M 485 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 76 / 565 Other M and F 22.15M 179 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 76 / 10,933 Other M and F 61.41M 260 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 323 / 1,604 Non European M and F 34.25M 278 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 323 / 27,747 Non European M and F 66.62M 223 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,325 / 12,172 European F 36.92M 354 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,325 / 247,974 European F 38.11M 523 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,485 / 13,040 Mixed F 48.88M 422 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,485 / 262,744 Mixed F 47.88M 484 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,402 / 11,077 European M 36.05M 349 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,402 / 208,549 European M 37.98M 332 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,565 / 11,813 Mixed M 46.48M 406 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,565 / 221,526 Mixed M 47.45M 432 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Population 416 / 486,904 Mixed M and F 47.70M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Population 375 / 458,875 European M and F 38.06M 365 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Positive Survivor 416 / 1,405 Mixed M and F 25.98M 159 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Positive Survivor 375 / 1,207 European M and F 17.85M 117 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Tested Survivor 416 / 17,302 Mixed M and F 49.04M 722 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Tested Survivor 375 / 16,068 European M and F 37.96M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 1,582 / 14,861 European M and F 37.96M 333 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 1,582 / 457,668 European M and F 38.06M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 1,821 / 15,897 Mixed M and F 49.04M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 1,821 / 485,499 Mixed M and F 47.70M 437 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 96 / 288 African M and F 21.83M 102 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 96 / 7,548 African M and F 43.68M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 80 / 362 South Asian M and F 13.89M 135 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 80 / 9,337 South Asian M and F 41.98M 548 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 63 / 386 Other M and F 19.92M 70 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 63 / 10,946 Other M and F 61.41M 189 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 239 / 1,036 Non European M and F 29.78M 250 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 239 / 27,831 Non European M and F 66.62M 238 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 736 / 7,709 European F 32.00M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 736 / 248,563 European F 38.11M 482 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 851 / 8,271 Mixed F 42.92M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 851 / 263,378 Mixed F 47.88M 300 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 846 / 7,152 European M 31.40M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 846 / 209,105 European M 37.98M 459 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 970 / 7,626 Mixed M 40.61M 339 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 970 / 222,121 Mixed M 47.45M 708 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 1,503 / 10,632 European M and F 35.77M 344 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 1,503 / 457,747 European M and F 38.06M 408 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 1,723 / 11,409 Mixed M and F 47.68M 340 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 1723 / 485,597 Mixed M and F 47.70M 411 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 88 / 229 African M and F 20.84M 98 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 88 / 7,556 African M and F No change since 07.14.20 analysis
UKBB 08.04.20 Positive vs. Negative (tested) 73 / 254 South Asian M and F 12.77M 137 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 73 / 9,344 South Asian M and F 41.98M 636 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 59 / 294 Other M and F 18.49M 71 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 59 / 10,950 Other M and F 61.41M 121 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 220 / 777 Non European M and F 27.56M 209 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 220 / 27,850 Non European M and F 66.62M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 699 / 5,452 European F 28.66M 205 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 699 / 248,600 European F 38.11M 352 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 804 / 5,887 Mixed F 39.16M 285 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 804 / 263,425 Mixed F 47.88M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 804 / 5,180 European M 28.35M 300 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 804 / 209,147 European M 37.98M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 919 / 5,522 Mixed M 37.00M 519 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 919 / 222,172 Mixed M 47.45M 590 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Population 364 / 486,956 Mixed M and F 47.70M 437 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Population 325 / 458,925 European M and F 38.06M 365 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Positive Survivor 364 / 1,306 Mixed M and F 25.16M 127 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Positive Survivor 325 / 1,129 European M and F 17.38M 130 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Tested Survivor 364 / 8,874 Mixed M and F 47.70M 403 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Tested Survivor 325 / 8,161 European M and F 31.99M 288 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 1,454 / 7,032 European M and F 31.99M 293 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 1,454 / 457,796 European M and F 38.06M 385 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 1,670 / 7,568 Mixed M and F 43.28M 304 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 1,670 / 485,650 Mixed M and F 47.70M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 88 / 167 African M and F 19.75M 70 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 88 / 7,556 African M and F 43.68M 334 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 70 / 167 South Asian M and F 11.77M 69 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 70 / 9,347 South Asian M and F 41.98M 761 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 58 / 202 Other M and F 16.94M 46 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 58 / 10,951 Other M and F 61.41M 228 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 674 / 3,611 European F 25.20M 260 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 674 / 248,625 European F 38.11M 345 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 778 / 3,917 Mixed F 35.00M 371 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 778 / 263,451 Mixed F 47.88M 404 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 780 / 3,421 European M 25.03 244 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 780 / 209,171 European M 37.98M 393 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 892 / 3,651 Mixed M 32.98M 418 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 892 / 222,199 Mixed M 47.45M 597 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 1,291 / 5,455 European M and F 29.61M 304 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 1,291 / 457,959 European M and F 38.06M 379 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 1,485 / 5,877 Mixed M and F 40.32M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 1,485 / 485,835 Mixed M and F 47.70M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 77 / 135 African M and F 18.87M 93 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 77 / 7,567 African M and F 43.68M 293 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 64 / 135 South Asian M and F 11.29M 47 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 64 / 9,353 South Asian M and F 41.98M 722 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 53 / 152 Other M and F 15.58M 89 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 53 / 10,956 Other M and F 61.41M 200 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 610 / 2,779 European F 22.13M 228 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 610 / 248,689 European F 38.11M 447 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 701 / 3,014 Mixed F 32.30M 308 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 701 / 263,528 Mixed F 47.88M 265 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 681 / 2,676 European M 23.09M 338 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 681 / 209,270 European M 37.98M 337 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 784 / 2,863 Mixed M 30.60M 313 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 784 / 222,307 Mixed M 47.45M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.05.20 Positive vs. Negative (tested) 1,221 / 4,117 European M and F 27.26 M 244 Summary Stats Annotated Grasp EBI GTeX eQTLdb
UKBB 06.05.20 Positive vs. Population 1,221 / 458,029 European M and F 38.06 M 406 Summary Stats Annotated Grasp EBI GTeX eQTLdb
UKBB 05.25.20 Positive vs. Negative (tested) 1,095/ 2,797 European M and F 24.33 M 172 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.25.20 Positive vs. Population 1,095 / 458,155 European M and F 38.06 M 448 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.07.20 Positive vs. Negative (tested) 880 / 1,686 European M and F 21.03 M 205 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.07.20 Positive vs. Population 880 / 458,370 European M and F 38.06 M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
Ellinghaus et al (link) 06.17.20 Covid-19 cases with respiratory failure vs Healthy controls 1,610 / 2,205 European M and F 8.58 M 391 Summary Stats Annotated Grasp EBI GTeX eQLdb GWAS adjusted for 10 PCs; Tops were lifted to hg19
Ellinghaus et al (link) 06.17.20 Covid-19 cases with respiratory failure vs Healthy controls 1,610 / 2,205 European M and F 8.58 M 317 Summary Stats Annotated Grasp EBI GTeX eQLdb GWAS adjusted for 10 PCs + age + sex; Tops were lifted to hg19
COVID19hg (link) 10.20.20 Very severe respiratory confirmed covid vs. not hospitalized covid (A1) 269 / 688 Mixed M and F 9.30M 81 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Very severe respiratory confirmed covid vs. population (A2) 4,336 / 623,902 Mixed M and F 11.83M 949 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Hospitalized covid vs. not hospitalized covid (B1) 2,430 / 8,478 Mixed M and F 14.90M 368 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Hospitalized covid vs. population (B2) 6,406 / 902,088 European M and F 9.87M 2394 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Hospitalized covid vs. population (B2) 7,885 / 961,804 Mixed M and F 11.43M 2748 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Covid vs. lab/self-reported negative (C1) 11,085 / 116,794 Mixed M and F 13.06M 224 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Covid vs. population (C2) 14,134 / 1,284,876 European M and F 11.58M 541 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Covid vs. population (C2) 17,965 / 1,370,547 Mixed M and F 12.71M 396 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (D1) 3,204 / 35,728 Mixed M and F 11.48M 88 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Very severe respiratory confirmed vs. population (A2 alpha) 2,972 / 284,472 Mixed M and F 12.82M 886 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Hospitalized covid vs. Not hospitalized covid (B1 alpha) 1,389 / 5,879 Mixed M and F 9.47M 66 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Hospitalized covid vs. Population (B2 alpha) 6,492 / 1,012,809 Mixed M and F 10.53M 978 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Covid vs. Lab/self-reported negative (C1 alpha) 11,181 / 116,456 Mixed M and F 13.91M 247 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Covid vs. Population (C2 alpha) 17,607 / 1,345,334 Mixed M and F 13.06M 476 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Predicted covid from self-reported symptoms vs. Predicted or self-reported non-covid (D1 alpha) 1,777 / 18,895 Mixed M and F 13.82M 106 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 06.26.20 Positive with severe respiratory vs. Population 536 / 329,391 Mixed M and F 9.31 M 60 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive Hospitalized vs. Positive Non Hospitalized 928 / 2,028 European M and F 12.03 M 130 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive Hospitalized vs. Population 3,199 / 897,488 Mixed M and F 15.39 M 453 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive vs. Lab/self reported Negative 3,523 / 36,634 Mixed M and F 22.04 M 153 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive vs. Population 6,696 / 1,073,072 Mixed M and F 20.59 M 377 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive (predict/self report) vs. Negative (predict/self report) 1,865 / 29,174 European M and F 12.27 M 169 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 05.13.20 Positive Hospitalized vs. Positive Non Hospitalized 716 / 616 Mixed M and F 10.98 M 958 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 05.13.20 Positive vs. Population 1,678 / 674,635 Mixed M and F 34.01 M 3,262 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 05.13.20 Positive (predict/self report) vs. Negative (predict/self report) 1,294 / 26,969 European M and F 7.52 M 544 Summary Stats Annotated Grasp EBI GTeX eQLdb



This work was supported by the NHLBI Intramural Research program and the NIH Biowulf high performance computing cluster (https://hpc.nih.gov/).